Navigation Links
AACR & IASLC to host molecular origins of lung cancer conference
Date:12/15/2011

What:

The second AACR-IASLC Joint Conference on Molecular Origins of Lung Cancer: Biology, Therapy and Personalized Medicine will bring together scientists to share the latest findings in the diagnosis, treatment and prevention of the nation's leading cause of cancer and cancer mortality.

The conference, scheduled for Jan. 8-11, 2012, in San Diego, is jointly sponsored by the American Association for Cancer Research and the International Association for the Study of Lung Cancer.

The conference will feature a series of groundbreaking oral presentations and hundreds of abstracts including:

  • prevention of tobacco damage using antiestrogens;
  • the role of tumor suppressor genes in small cell lung cancer;
  • a phase 2 study of sorafenib in patients with stage IV disease;
  • new tools to measure circulating tumor cells;
  • new data on microRNA and KRAS mutations

When:

Jan. 8-11, 2012

Where: San Diego Marriott Hotel & Marina San Diego, Calif.


'/>"/>
Contact: Natalie Poole
Natalie.Poole@aacr.org
215-446-7155
American Association for Cancer Research
Source:Eurekalert

Page: 1

Related biology news :

1. AVS 55th International Symposium & Exhibition, Oct. 19-24
2. Brown University and Women & Infants Hospital expand national childrens study to Bristol County
3. Genetic Engineering & Biotechnology News reports on growing role of molecular diagnostics
4. Columbia to award 2008 Horwitz Prize to Arthur Horwich & Ulrich Hartl for cellular protein folding
5. Singapore opens Fusionopolis, its second major R&D hub in 5 years
6. The Camille & Henry Dreyfus Foundation to host important symposium on chemistry and the environment
7. Texas A&M anthropologist discovers long-lost primate in Indonesia
8. Genetic Engineering & Biotechnology News reports on the trend toward predictive toxicogenomics
9. Ancestral genome of present-day African great apes & humans had burst of DNA sequence duplication
10. NTU seals global partnerships on environmental sciences R&D
11. UTSA, Health Science Center collaborate with Merck & Co. to develop chlamydia vaccine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/21/2016)... 2016 NuData Security announced today that Randy ... principal product architect and that Jon Cunningham ... development. Both will report directly to Christopher ... reflect NuData,s strategic growth in its product and ... demand and customer focus values. ...
(Date:6/16/2016)... June 16, 2016 The ... expected to reach USD 1.83 billion by 2024, ... Research, Inc. Technological proliferation and increasing demand in ... expected to drive the market growth. ... The development of advanced multimodal techniques for ...
(Date:6/9/2016)...  Perkotek an innovation leader in attendance control systems is proud to announce the ... employers to make sure the right employees are actually signing in, and to even ... ... ... ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... NC (PRWEB) , ... June 27, 2016 , ... ... mission to bring innovative medical technologies, services and solutions to the healthcare market. ... and implementation of various distribution, manufacturing, sales and marketing strategies that are necessary ...
(Date:6/24/2016)... SAN DIEGO , June 24, 2016 /PRNewswire/ ... that more sensitively detects cancers susceptible to PARP ... individual circulating tumor cells (CTCs). The new test ... of HRD-targeted therapeutics in multiple cancer types. ... therapies targeting DNA damage response pathways, including PARP, ...
(Date:6/23/2016)... , June 23, 2016   Boston ... of novel compounds designed to target cancer stemness ... has been granted Orphan Drug Designation from the ... treatment of gastric cancer, including gastroesophageal junction (GEJ) ... inhibitor designed to inhibit cancer stemness pathways by ...
(Date:6/23/2016)... , June 23, 2016  The Prostate Cancer Foundation (PCF) is ... treatments and faster cures for prostate cancer. Members of the Class of 2016 ... countries. Read More About the Class of 2016 PCF ... ... ...
Breaking Biology Technology: